Nathan Rich
Stock Analyst at Goldman Sachs
(0.99)
# 3,933
Out of 5,131 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $16.90 | +24.26% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $126.85 | +54.51% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.48 | +140.38% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $13.20 | -39.39% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $23.62 | -25.91% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $277.57 | +38.70% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $23.24 | -39.76% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $32.51 | -66.16% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $170.58 | +31.90% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $712.39 | -8.76% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $80.60 | +9.18% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $20.95 | -42.72% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $79.00 | +7.59% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $12.60 | -12.70% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $183.50 | +82.56% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $346.85 | +54.25% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $16.90
Upside: +24.26%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $126.85
Upside: +54.51%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.48
Upside: +140.38%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $13.20
Upside: -39.39%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $23.62
Upside: -25.91%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $277.57
Upside: +38.70%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $23.24
Upside: -39.76%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $32.51
Upside: -66.16%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $170.58
Upside: +31.90%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $712.39
Upside: -8.76%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $80.60
Upside: +9.18%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $20.95
Upside: -42.72%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $79.00
Upside: +7.59%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $12.60
Upside: -12.70%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $183.50
Upside: +82.56%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $346.85
Upside: +54.25%